We are live on ! Find out more
AMCA

Arthur M. Cohen & Associates Portfolio holdings

AUM $563M
1-Year Est. Return 20.97%
This Fund
S&P 500
This Quarter Est. Return
+4.4%
1 Year Est. Return
+20.97%
3 Year Est. Return
+97.14%
5 Year Est. Return
+130.41%
10 Year Est. Return
–
AUM
$292M
AUM Growth
+$12.1M
Cap. Flow
-$12.5M
Cap. Flow %
-4.26%
Top 10 Hldgs %
58.59%
Holding
120
New
7
Increased
34
Reduced
45
Closed
4

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$1.14M
2
PGR icon
Progressive
PGR
+$1.1M
3
RTX icon
RTX Corp
RTX
+$448K
4
BLK icon
Blackrock
BLK
+$360K
5
ISRG icon
Intuitive Surgical
ISRG
+$317K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$6.88M
2
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$1.55M
3
ILMN icon
Illumina
ILMN
+$1.14M
4
WFC icon
Wells Fargo
WFC
+$879K
5
SAGE
Sage Therapeutics
SAGE
+$782K

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Financials 18.95%
3 Technology 12.54%
4 Consumer Discretionary 7.76%
5 Consumer Staples 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BN icon
101
Brookfield
BN
$108B
$266K 0.09%
15,622
– –
IWO icon
102
iShares Russell 2000 Growth ETF
IWO
$15B
$265K 0.09%
1,320
+2
+0.2% +$396
ASMB icon
103
Assembly Biosciences
ASMB
$524M
$263K 0.09%
1,625
– –
BDX icon
104
Becton Dickinson
BDX
$48.5B
$249K 0.09%
1,012
-51
-5% -$11.8K
CHD icon
105
Church & Dwight Co
CHD
$24.4B
$240K 0.08%
3,286
– –
XLI icon
106
State Street Industrial Select Sector SPDR ETF
XLI
$33.7B
$224K 0.08%
2,897
– –
VUG icon
107
Vanguard Morningstar Growth ETF
VUG
$231B
$211K 0.07%
8,130
+24
+0.3% +$641
KMB icon
108
Kimberly-Clark
KMB
$36.3B
$210K 0.07%
1,578
-220
-12% -$28.4K
VTI icon
109
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
$210K 0.07%
+1,340
New +$197K
BLUE
110
DELISTED
bluebird bio
BLUE
$205K 0.07%
124
-124
-50% -$215K
UN
111
DELISTED
Unilever NV New York Registry Shares
UN
$204K 0.07%
+3,360
New +$201K
GE icon
112
GE Aerospace
GE
$382B
$202K 0.07%
3,862
+1,299
+51% +$63.9K
ASAP
113
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$89K 0.03%
+708
New +$121K
LPTH icon
114
Lightpath Technologies
LPTH
$794M
$41K 0.01%
45,000
– –
GNMX
115
DELISTED
Aevi Genomic Medicine Inc
GNMX
$10K ﹤0.01%
+64,390
New +$13K
AGIO icon
116
Agios Pharmaceuticals
AGIO
$1.9B
– –
-7,612
Closed -$513K
BMY icon
117
Bristol-Myers Squibb
BMY
$131B
– –
-8,745
Closed -$417K
IWR icon
118
iShares Russell Mid-Cap ETF
IWR
$57.3B
– –
-7,366
Closed -$397K
USG
119
DELISTED
Usg
USG
– –
-4,830
Closed -$209K
1 2 3 4
5

Similar funds

PDL
Portfolio Design Labs Encino, California $562M AUM 20.39% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM
MCM
Maytus Capital Management New York $562M AUM 71.97% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return

Arthur M. Cohen & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Arthur M. Cohen & Associates held 120 positions worth $292M, up 4.3% from $280M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Arthur M. Cohen & Associates withdrew a net $12.5M in Q2 2019, closing 4 positions and reducing 45 holdings. Its most notable exit was Agios Pharmaceuticals, an estimated $513K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Arthur M. Cohen & Associates opened a new position in iShares Russell 1000 ETF worth $399K.

  • Arthur M. Cohen & Associates's largest Q2 2019 buy was iShares Russell 1000 ETF: 7,134 shares worth $399K.
  • Arthur M. Cohen & Associates added most to RTX Corp in Q2 2019, an estimated $448K increase.
  • Arthur M. Cohen & Associates's biggest Q2 2019 reduction was Amgen, cutting an estimated $6.88M.
  • Arthur M. Cohen & Associates fully exited Agios Pharmaceuticals in Q2 2019, selling an estimated $513K.
  • Arthur M. Cohen & Associates's ten largest holdings make up 59% of its $292M portfolio in Q2 2019.
  • Arthur M. Cohen & Associates opened 7 new positions and closed 4 in Q2 2019.
  • Arthur M. Cohen & Associates's portfolio value rose 4.3% quarter-over-quarter to $292M.

Based on Arthur M. Cohen & Associates's 13F filing for Q2 2019, filed 29 Jul 2019.